- Molecular Biology
- Viral Vectors & Cell Engineering
- Protein Engineering & Production
- Antibody Discovery & Engineering
- Antibody Production
-
Analytics & Formulation
- Overview
- Purity Analysis by CE-SDS
- Aggregation Analysis
- Charge Variant Analysis
- De Novo Antibody Sequencing
- Intact Mass Analysis
- Sequence Confirmation by Mass Spectrometry
- N-terminal Sequencing
- Post-Translational Modification
- N-glycan Analysis
- Thermostability Analysis
- Stability Analysis
- Formulation Development
- Developability Analysis
- R&D and cGxP Bioassay Development
- Protein Chemistry
- Development & Manufacturing in LakePharma Hayward, CA
- Development & Manufacturing in LakePharma Hopkinton, MA
- Consulting Services
AAV
The Vector Technology group utilizes the baculovirus platform for production of AAV, with a focus on vector engineering and optimization, process development, and scale-up production. The technical team at LakePharma has over 16 years of experience utilizing suspension insect cell lines and the baculovirus system for production of recombinant proteins and the AAV platform expands on those capabilities. Extensive characterization capabilities are also available with LakePharma's assay group.
Click here to download our Viral Vector Presentation.